An organoid model with barrier structure and construction method thereof

By co-culture of endothelial cells and perivascular cells in organoid chips, a long-term homeostasis co-culture system for functionalized blood-brain barrier structure and brain organoids is solved, and the problem of lack of blood-brain barrier structure in the existing technology is improved. The efficiency and accuracy of drug development.

CN117384760BActive Publication Date: 2024-11-29WUHAN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202310548218.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-29
Estimated Expiration
2043-05-12

AI Technical Summary

Technical Problem

The existing technology is difficult to build a high-fidelity human-source brain model with blood-brain barrier function, resulting in difficulty in developing drugs in the central nervous system, poor drug permeability testing and drug efficacy evaluation, and high cost and ethical problems in animal models.

Method used

Design an organoid chip with integrated microporous components to construct functional blood-brain barrier structure and brain organoids by co-culturing endothelial cells and perivascular cells on both sides of the porous membrane. Long-term steady-state co-cultivation system.

Benefits of technology

The functional construction of blood-brain barrier structure and long-term homeostasis co-culture have been realized, which has improved the bionicity and fidelity of the brain model, simplified the fluid implementation conditions, and promoted the permeability test and efficacy evaluation of central nervous system drugs. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117384760B_ABST
    Figure CN117384760B_ABST
Patent Text Reader

Abstract

The present invention discloses an organoid model with a barrier structure and a construction method thereof, the method comprising: obtaining an organoid chip with a barrier structure, comprising: a cell culture plate; an integrated microporous component arranged in the cell culture plate, comprising, from top to bottom, an upper element, a porous membrane and a lower element; the upper element comprises a first and a second hollow part, the first hollow part is divided into two left and right culture medium reservoirs by the second hollow part, and the second hollow part is provided with the porous membrane at the bottom to form a culture medium addition pool; the lower element is hollow, and the bottom of the left and right culture medium reservoirs forms a culture medium perfusion channel through the lower element. A variety of barrier cells are inoculated on the upper and lower sides of the porous membrane in sequence, the organoid is loaded into the culture medium addition pool, and the chip is placed on a seesaw shaker for long-term dynamic culture. The fluid implementation conditions are simplified, and the bionics and fidelity of the organoid model with a barrier structure are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of tissue engineering and organoid chip, and in particular to an organoid model with a barrier structure and a construction method thereof. Background Art

[0002] According to estimates by the World Health Organization, nearly one in six people in the world currently suffer from central nervous system (CNS) diseases, including cerebral infarction, cerebral hemorrhage, meningitis, demyelinating diseases and neurodegeneration. Patients with CNS diseases need to take central nervous system drugs for a long time to treat neurological dysfunction or alleviate the process of neurodegeneration, and the market size of CNS drugs has therefore expanded rapidly. China's CNS drug sales have increased from 144 billion yuan in 2015 to 204.3 billion yuan in 2019, with a compound annual growth rate of 9.1%. It is expected to further grow at a compound annual growth rate of 4.6% from 2020 to 2024, reaching 250.9 billion yuan in 2024.

[0003] However, the CNS drug market exhibits high-risk, high-return characteristics compared to other therapeutic areas. Clinical trials show that the development of CNS drugs is very difficult, with a success rate of only 8.4% from clinical phase I to market launch, and an overall success rate of only 6.2%. It takes as long as 19.3 months to obtain approval from the U.S. Food and Drug Administration (FDA). Between 2009 and 2011, the number of publicly visible clinical CNS projects of 10 large pharmaceutical companies fell by 50%, venture capital for new drug development fell by 56%, venture capital for neurology fell by 39%, and oncology fell by less than 5%.

[0004] Specifically, the difficulties in CNS drug development are mainly: 1. The exact cause and pathogenesis of many CNS diseases have not yet been determined, and drugs can only treat the symptoms but not the root cause; 2. The existing CNS preclinical models have low fidelity, resulting in low success rates of developed therapeutic targets or methods in clinical trials; 3. The high barrier properties of the blood-brain barrier (BBB) ​​prevent peripheral intravenous drugs from reaching the brain at an effective pharmacological concentration, and the drug treatment effect is difficult to truly reflect; 4. CNS drugs are often accompanied by obvious side effects, which can easily cause chronic encephalitis, hypertension, suicidal tendencies, etc. Therefore, it is urgent to develop a high-fidelity brain model with a blood-brain barrier to construct a variety of CNS disease models and study related pathogenesis, and promote the research and development of CNS drugs such as permeability testing, efficacy evaluation, and drug toxicity evaluation.

[0005] The brain of the animal model naturally has a blood-brain barrier and brain parenchyma tissue, but there are obvious differences from the human brain, which is one of the main factors leading to the low success rate of drug development. The important differences between the human brain and the animal brain are brain volume, glial cells, neurogenesis, cortical composition, etc. Compared with humans, the brain volume, glial cell to neuron ratio of most animals are relatively small, and the rate of neurogenesis is also different. The cortical cell types of animal brains are highly conserved, but there are great differences from the human brain in terms of cell proportions, gene expression levels and hierarchical distribution, which cannot completely simulate and reflect human brain tissue, so many brain science studies cannot find answers in animal models. In addition, animal models also have high costs, long R&D cycles, and moral and ethical issues. Therefore, constructing a human brain model with a blood-brain barrier structure in vitro is the main challenge for CNS drug development.

[0006] The in vitro blood-brain barrier model has developed from the Transwell system to the emerging organ model, which can realize the contact culture of BBB cells and the simulation of blood flow shear force. It has the advantages of low cost, easy operation, and controllable conditions. It can be used for pathophysiological research of the barrier and drug permeability testing. Brain organoids are excellent representatives of brain substance. They are formed by self-organization and differentiation of stem cells into microscale brain tissue. They have a variety of neural cell types and a specific three-dimensional tissue structure. They can simulate the pathological phenotype of CNS diseases and conduct drug efficacy evaluation and toxicity testing. They have the advantages of low cost, easy operation, controllable conditions and microenvironment, and low ethical risks.

[0007] Organ chip technology and organoid technology are widely used, but there are still no research reports on human brain organoid models with blood-brain barrier. The reasons may be: 1. The co-culture system of multiple BBB cell types is complex, and the BBB structure cannot maintain the barrier function related to human physiology for a long time; 2. The culture systems of brain organoids and BBB structures are quite different, and the co-culture system is difficult to build. The biological morphological structure and physiological function of brain organoids are difficult to ensure during the co-culture process; 3. The problem of maintaining the steady state of BBB structure and brain organoids in long-term dynamic co-culture, etc.

[0008] In short, we can screen a conditioned medium for co-cultured BBB cells, which helps to functionalize the BBB structure. Furthermore, by building a co-culture system of BBB and brain organoids, long-term steady-state co-culture of functionalized BBB structure and human brain organoids can be performed, solving the limitations of brain organoids lacking BBB structure and functionalized BBB lacking brain parenchymal tissue. The human brain organoid model with blood-brain barrier that we developed is of great significance for promoting related research on permeability testing of CNS drugs, drug efficacy evaluation and drug toxicity testing. Summary of the invention

[0009] The purpose of the present invention is to provide an organoid model with a barrier structure and a construction method to achieve the construction of a functionalized BBB structure and the suspension maintenance culture of human brain organoids. By co-culturing the functionalized BBB structure with human brain organoids for a long time in a steady state, the limitations of human brain organoids lacking a BBB structure and functionalized BBB lacking brain parenchymal tissue are solved. The fluid implementation conditions are further simplified, and the bionics and fidelity of the brain blood-brain barrier model are improved. The model is helpful to promote the testing or research of CNS drug permeability, efficacy evaluation and toxicity evaluation.

[0010] In order to achieve the above object, the present invention adopts the following technical solution:

[0011] In a first aspect of the present invention, a method for constructing an organoid model with a barrier structure is provided, the method comprising:

[0012] An organoid chip with a barrier structure is obtained, comprising: a cell culture plate and an integrated microporous component arranged in the cell culture plate, wherein the integrated microporous component comprises, from top to bottom, an upper element, a porous membrane and a lower element; the upper element comprises a first hollow part and a second hollow part, wherein a pair of oppositely arranged side walls of the first hollow part are both in contact with the inner wall of the cell culture plate, the middle part of the first hollow part is clamped with the second hollow part, the second hollow part divides the first hollow part into a left culture medium reservoir and a right culture medium reservoir, and the bottom of the second hollow part is provided with the porous membrane to form a culture medium addition reservoir; the lower element is hollow and the outer shape of the lower element is adapted to the outer peripheral shape of the first hollow element, the middle upper surface of the lower element is used to support the porous membrane, and the bottom of the left culture medium reservoir and the bottom of the right culture medium reservoir are connected through the bottom of the lower element to form a culture medium perfusion channel;

[0013] After sterilizing the organoid chip with a barrier structure, the porous membrane is coated; the endothelial cell culture medium and the culture medium of the cells for enhancing the barrier structure are prepared in a volume ratio of 1:9-4:6 to obtain a conditioned medium; the endothelial cells are inoculated on one side of the coated porous membrane, the cells for enhancing the barrier structure are inoculated on the other side of the coated porous membrane, and the endothelial cells and the cells for enhancing the barrier structure are co-cultured using the conditioned medium;

[0014] After 12 to 72 hours of co-culture, the organoid is loaded into the culture medium addition tank of the organoid chip with a barrier structure, and the conditioned culture medium and the organoid maturation culture medium are added to the culture medium reservoir and the culture medium addition tank, respectively. The organoid is then placed on a precision seesaw shaker for long-term static or dynamic co-culture of the functionalized barrier structure and the organoid to obtain an organoid model with a barrier structure.

[0015] In a second aspect of the present invention, an organoid model with a barrier structure prepared by the method is provided.

[0016] In a third aspect of the present invention, a brain organoid chip with a barrier structure is provided, characterized in that the brain organoid chip with a barrier structure comprises:

[0017] Cell culture plates;

[0018] An integrated microporous component is arranged in the cell culture plate; the integrated microporous component includes, from top to bottom, an upper element, a porous membrane and a lower element; the upper element includes a first hollow part and a second hollow part, a pair of oppositely arranged side walls of the first hollow part are both in contact with the inner wall of the cell culture plate, the middle part of the first hollow part is clamped with the second hollow part, the second hollow part divides the first hollow part into a left culture medium reservoir and a right culture medium reservoir, and the bottom of the second hollow part is provided with the porous membrane to form a culture medium addition tank; the lower element is hollow and the outer shape of the lower element is adapted to the outer peripheral shape of the first hollow element, the middle upper surface of the lower element is used to support the porous membrane, the bottom of the left culture medium reservoir and the bottom of the right culture medium reservoir are connected through the bottom of the lower element to form a culture medium perfusion channel.

[0019] Furthermore, the height of the first hollow member is 2-15 mm; the height of the lower layer element is 0.5-3 mm.

[0020] Furthermore, the thickness of the porous membrane is 5 to 20 μm, the pore size is 0.1 to 3 μm, and the porosity is 1×10 5 ~5×10 6 Hole / cm 2 .

[0021] One or more technical solutions in the embodiments of the present invention have at least the following technical effects or advantages:

[0022] 1. The organoid chip with a barrier structure provided by the present invention integrates the functional human blood-brain barrier structure and human brain organoids, which solves the species difference problem of the existing blood-brain barrier model and reproduces the complex cell types and tissue structure of the brain parenchyma to a certain extent.

[0023] 2. The present invention designs a chip with a sandwich structure component formed by upper and lower layer elements and a porous membrane, which facilitates the co-culture of blood-brain barrier cells on both sides of the porous membrane, and the cultivation of brain organoids in the culture medium liquid pool formed by the upper layer element and the porous membrane, thereby achieving long-term steady-state co-culture of the two and simplifying the construction, assembly and application methods of the chip.

[0024] 3. The present invention designs a substrate, a culture medium storage tank, a culture medium perfusion channel and a culture medium adding tank, and relies on a precision seesaw shaker to provide gravity flow, which is conducive to forming a two-way fluid flow between the lower layer elements and the substrate, avoiding the design of complex fluid channels and the use of multiple perfusion equipment, and simplifying the fluid implementation conditions.

[0025] 4. The present invention uses the culture wells of the cell culture plate as the substrate, which is beneficial to maintaining the activity of cells and brain organoids, has stronger biocompatibility, and is suitable for large-scale production.

[0026] 5. The chip designed in the present invention has a simple structure and is easy to assemble, which simplifies the construction process of organoid models with barrier structures, is convenient for operation by personnel in related fields, is highly user-friendly, and has great application prospects and commercial value. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0028] Figure 1 A schematic diagram of an organoid chip with a barrier structure in the present invention;

[0029] The reference numerals are as follows:

[0030] 1. Cell culture plate;

[0031] 2. Integrated microporous component; 21. Upper layer element; 211. First hollow member; 212. Second hollow member; 22. Porous membrane; 23. Lower layer element;

[0032] 3. Left culture medium reservoir;

[0033] 4. Right culture medium reservoir;

[0034] 5. Culture medium adding tank;

[0035] 6. Culture medium perfusion channel;

[0036] Figure 2 This is a schematic diagram of the assembly of the organoid chip with a barrier structure in the present invention;

[0037] Figure 3 This is a nutrient diffusion distribution diagram of the organoid chip with a barrier structure in the present invention;

[0038] Figure 4 A culture scheme for the organoid model with barrier structure in the present invention;

[0039] Figure 5 The effect of the conditioned medium of the present invention on blood-brain barrier cells; wherein, Figure 5 A is the effect of conditioned medium on the activity of human brain microvascular endothelial cells; Figure 5 B is RT-qPCR identification of human brain microvascular endothelium in conditioned medium; Figure 5 C is the effect of conditioned medium on the activity of vascular pericytes; Figure 5 D is RT-qPCR identification of vascular pericytes in conditioned medium; Figure 5 E is the immunofluorescence identification of human brain microvascular endothelium in conditioned medium; Figure 5 F is the immunofluorescence identification of vascular pericytes in conditioned medium;

[0040] Figure 6 This is the bright field imaging of the co-culture of blood-brain barrier cells and brain organoids in the present invention; wherein, Figure 6 A is a bright field image of a human brain microvascular endothelial cell monolayer; Figure 6 B is a bright field image of the human brain microvascular endothelial monolayer and perivascular cell monolayer; Figure 6 C is a bright field image of a brain organoid with a blood-brain barrier; Figure 6 D is a bright field image of human brain microvascular endothelial monolayer and brain organoids;

[0041] Figure 7 The present invention is an immunofluorescence analysis of the blood-brain barrier in the brain organoid model with a blood-brain barrier; wherein, Figure 7 AB is immunofluorescence analysis of human brain microvascular endothelial cells; Figure 7 C is an immunofluorescence analysis of human brain vascular pericytes; Figure 7 D is the combined immunofluorescence image analysis of human brain microvascular endothelial cells and human brain vascular pericytes;

[0042] Figure 8 The present invention provides a functional analysis of the blood-brain barrier in the brain organoid model with a blood-brain barrier; wherein, Figure 8 A is the change trend of the resistance value of the blood-brain barrier; Figure 8 B is the macromolecular permeability of the blood-brain barrier; Figure 8 C is the small molecule permeability of the blood-brain barrier;

[0043] Fig. 9 It is an RT-qPCR analysis of the functional genes of the blood-brain barrier in the brain organoid model with the blood-brain barrier in the present invention; wherein, Fig. 9 AB is the tight junction expression of the blood-brain barrier; Fig. 9 CD is the expression of pericyte functional genes of the blood-brain barrier;

[0044] Fig.10The present invention is an immunofluorescence analysis of human brain organoids in the brain organoid model with a blood-brain barrier; wherein, Fig.10 A is the cell type identification of human brain organoids; Fig.10 B is the identification of brain region structures of human brain organoids;

[0045] Fig.11 The RT-qPCR analysis of human brain organoids in the brain organoid model with blood-brain barrier in the present invention; wherein, Fig.11 A is the cell type identification of human brain organoids; Fig.11 B is the identification of brain region structures of human brain organoids;

[0046] Fig.12 The data of batch-to-batch differences in background resistance values ​​measured after coating of organoid chips with barrier structures. DETAILED DESCRIPTION

[0047] The present invention will be described in detail below in conjunction with specific implementations and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific implementations and examples are used to illustrate the present invention, rather than to limit the present invention.

[0048] Throughout the specification, unless otherwise specifically stated, the terms used herein should be understood as meanings commonly used in the art. Therefore, unless otherwise defined, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. In the event of a conflict, the present specification takes precedence.

[0049] It should be noted that when an element is referred to as being "fixed on" or "provided on" another element, it can be directly on the other element or indirectly provided on the other element; when an element is referred to as being "connected to" another element, it can be directly connected to the other element or indirectly connected to the other element.

[0050] It should be understood that the terms "length", "width", "up", "down", "front", "back", "first", "second", "vertical", "horizontal", "top", "bottom", "inside", "outside", etc., indicating the orientation or position relationship, are based on the orientation or position relationship shown in the drawings, and are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as a limitation on the present application.

[0051] In addition, in the description of the present application, “multiple” and “several” mean two or more, unless otherwise clearly and specifically defined.

[0052] In the embodiment of the present invention, the Chinese name of BMECs is human brain microvascular endothelial cells; the Chinese name of BVPs is human brain vascular pericytes.

[0053] The overall idea of ​​the technical solution provided by the present invention is as follows:

[0054] According to a typical embodiment of the present invention, a brain organoid chip with a blood-brain barrier is provided, such as Figure 1 As shown, including:

[0055] A cell culture plate 1; an integrated microporous component 2, arranged in the cell culture plate 1; the integrated microporous component 2 comprises, from top to bottom, an upper element 21, a porous membrane 22 and a lower element 23; the upper element 22 comprises a first hollow part 211 and a second hollow part 212, wherein a pair of oppositely disposed side walls of the first hollow part 211 are both in contact with the inner wall of the cell culture plate 1, the middle of the first hollow part 211 is clamped with the second hollow part 212, and the second hollow part 212 connects the first hollow part 211 is separated into a left culture medium reservoir 3 and a right culture medium reservoir 4, and the bottom of the second hollow part 212 is provided with the porous membrane 22 to form a culture medium liquid adding tank 5; the lower layer element 23 is hollow and the outer shape of the lower layer element 23 is adapted to the outer peripheral shape of the first hollow part 211, and the middle upper surface of the lower layer element 23 is used to support the porous membrane 22, and the bottom of the left culture medium reservoir 3 and the bottom of the right culture medium reservoir 4 are connected through the bottom of the lower layer element 23 to form a culture medium perfusion channel 6.

[0056] like Figure 1 As shown, when the present invention is used, BMECs and cells for enhancing barrier structure (such as BVPs) are inoculated successively on both sides (lower side and upper side, or upper side and lower side) of the porous membrane, and the porous membrane and the base of the cell culture plate form a perfusion channel, and the gravity of the precision seesaw shaker provides fluid flow for the lower or upper BMECs monolayer to simulate the in vivo brain microvascular blood flow and the fluid shear force applied to the endothelial lumen, thereby solving the limitations of the perfusion channel and the complex fluid implementation conditions of the existing in vitro BBB model. Long-term co-culture of human brain microvascular endothelial cells (BMECs) and cells for enhancing barrier structure (such as BVPs) under dynamic conditions can form a functional BBB (a highly selective barrier between brain blood and brain parenchyma) structure. The upper element is arranged on a porous membrane to form a culture medium addition pool. Human brain organoids with complex brain parenchymal cell types and three-dimensional structural characteristics are added to the culture medium addition pool. Long-term steady-state co-culture of functional BBB structure and human brain organoids can form a brain organoid model with BBB, thereby solving the problem that the existing in vitro BBB model lacks brain parenchymal structure.

[0057] In the above technical solution, the cell culture plate 1 includes a 48-well plate, a 24-well plate, a 12-well plate, a 6-well plate, a 3.5 cm culture dish, a 6 cm culture dish, a 10 cm culture dish, and a glass slide. The present invention is obtained by processing the common cell culture plates on the market, which conforms to the operating habits of biologists and is compatible with various optical instruments.

[0058] In the above technical scheme, the manufacturing method of the integrated microporous component is to use PDMS to bond the hollow cross-section of the second hollow part of the upper element to the porous membrane, and then bond it to the middle upper surface cross-section of the lower element. The porous membrane is embedded in the upper element and the lower element by means of the cured PDMS.

[0059] In the technical solution, one pair of oppositely disposed side walls of the first hollow member are both in contact with the inner wall of the cell culture plate. Therefore, since the cell culture plates are all circular, the shapes of one of the oppositely disposed side walls of the first hollow member are both arc-shaped to adapt to the cell culture plate. The shape of the other oppositely disposed side walls of the first hollow member is not limited, and can be straight, wavy, or arc-shaped.

[0060] Since the lower layer element is hollow and the outer shape of the lower layer element is adapted to the outer peripheral shape of the first hollow part, the shapes of two oppositely disposed side walls of the lower layer element are both arc-shaped and adapted to the cell culture plate.

[0061] As a specific embodiment, the hollow cross section of the second hollow part is in the shape of a circular ring, an elliptical ring, a semicircular ring, a fan ring, a triangular ring, a quadrilateral ring, a pentagonal ring, a hexagonal ring, or any polygonal ring. The second hollow part is clamped in the middle of the first hollow part, that is, if the second hollow part is in the shape of a circular ring, and the two side walls of the first hollow part that are not in contact with the cell culture plate are straight, then the second hollow part is inscribed in the first hollow part.

[0062] As a preferred embodiment, the height of the first hollow part is 2-15 mm; therefore, the height of the second hollow part is also 2-15 mm, and the height of the first hollow part is equal to the height of the second hollow part. If the height of the first hollow part is less than 2 mm, there is an adverse effect that the culture medium addition pool cannot be formed; if it is higher than 15 mm, there is an adverse effect that it cannot be matched with the height of the well of the cell culture plate;

[0063] As a preferred embodiment, the height of the lower layer element is 0.5 to 3 mm. If the height is lower than 0.5 mm, it is difficult to form fluid flow through the precision seesaw shaker; if it is higher than 3 mm, it is difficult to select the fluid flow rate through the precision seesaw shaker; since the lower layer element has a certain height, the middle upper surface of the lower layer element is used to support the porous membrane, and the bottom of the porous mold is at a certain height from the bottom of each culture well of the cell culture plate, so that the bottom of the left culture medium reservoir is connected to the bottom of the right culture medium reservoir to form a culture medium perfusion channel;

[0064] As a preferred embodiment, the linear distance between the two opposite side walls of the first hollow part is 10.2-34.8 mm, the linear distance between the two opposite side walls of the lower layer element is 10.2-34.8 mm, and the first hollow part and the lower layer element have the same outer dimensions.

[0065] The shape of the culture medium reservoir is not limited. When the hollow cross section of the second hollow member of the upper element is annular, the culture medium reservoir is in the shape of an arch column for adding culture medium. As an optional embodiment, the culture medium reservoir is 3 to 12 mm long, 3 to 12 mm wide, and 2.5 to 18 mm high.

[0066] The culture medium perfusion channel is playground-shaped and is used for bidirectional flow of culture medium. It is 10.2 to 34.8 mm long, 10.2 to 34.8 mm wide, and 0.5 to 3 mm high.

[0067] When the hollow cross section of the second hollow part of the upper element is in the shape of a circular ring, the culture medium sample reservoir is cylindrical, used for adding and removing culture medium, with a diameter of 3 to 12 mm and a height of 2 to 15 mm;

[0068] As a preferred embodiment, the thickness of the porous membrane is 5 to 20 μm, the pore size is 0.1 to 3 μm, and the porosity is 1×10 5 ~5×10 6 Hole / cm 2 The porous membrane is used to form a perfusion channel with the base of the cell culture plate, allowing the culture medium in the culture medium reservoir to pass through and generating a certain fluid shear force on the cells on the upper and lower sides of the porous membrane. If the thickness of the porous membrane is less than 5 μm, it will have the adverse effect of being easily broken during the manufacture of the integrated microporous component. If it is greater than 20 μm, it will have the adverse effect of preventing the barrier cells from contacting each other.

[0069] Furthermore, the material of the above-mentioned integrated microporous component is an acrylic (PMMA) plate with good biocompatibility, and other microporous plate materials, such as polycarbonate (PC), polydimethylsiloxane (PDMS), pure glass and the like, may also be used.

[0070] Furthermore, the material of the porous membrane is polyethylene terephthalate (PET) with good optical transmittance, and other porous membrane materials may also be used, such as polytetrafluoroethylene (PTFE), polycarbonate (PC), fluorinated polyethylene polymer (FEP), glass fiber membrane, cellulose acetate membrane, etc.

[0071] As a specific embodiment, the method for preparing the organoid chip with a barrier structure comprises:

[0072] Step 1. For different human cell types or other culture sizes, the upper and lower components of the microplate are designed using CAD software according to their sizes;

[0073] Step 2: Use laser engraving technology or CNC machine tool engraving technology to process the PMMA plate to make upper and lower layer components;

[0074] Step 3, cutting the porous membrane according to the center shape of the upper element;

[0075] Step 4: Use PDMS to adhere the PMMA upper and lower layer components to the porous membrane to form a sandwich structure component, and further adhere the lower layer component side of the sandwich structure component to the cell culture plate to form a microporous plate;

[0076] Step 5, the microplate structure includes a substrate, a culture medium reservoir, a culture medium perfusion channel, and a culture medium addition reservoir;

[0077] Step 6. Use COMSOL software to model the designed chip and perform simulation verification of fluid flow, flow rate and material diffusion in the chip to confirm that there is stable fluid flow and physiologically relevant fluid shear force in the chip, and that the porous membrane separating the upper and lower chambers can achieve material diffusion.

[0078] Step 7, sterilize the integrated microporous component by ultraviolet for 48 hours, and perform a leak test for 4 hours. The substances used for the leak test include PBS, dyes, pigments, fluorescein, ink, etc.;

[0079] Step 8, pouring gelatin solution into the lower channel of the microplate, so that the liquid stays between the microplate base and the porous membrane by surface tension, and the porous membrane of the microplate is coated in a 37° C. incubator for 2-4 hours;

[0080] Step 9: Remove the gelatin solution from the microplate and place the microplate in a biosafety cabinet or clean bench to air dry for 20 minutes.

[0081] According to another typical embodiment of the present invention, a method for constructing a brain organoid model with a blood-brain barrier based on an organoid chip is provided, comprising the following steps:

[0082] After sterilizing the brain organoid chip, the porous membrane is coated; the endothelial cell culture medium and the culture medium of the cells for enhancing the barrier structure are prepared in a volume ratio of 1:9-4:6 to obtain a conditioned medium; the endothelial cells are inoculated on one side of the coated porous membrane, and the cells for enhancing the barrier structure are inoculated on the other side of the coated porous membrane, and the endothelial cells and the cells for enhancing the barrier structure are co-cultured using the conditioned medium;

[0083] After 12 to 72 hours of co-culture, the organoid is loaded into the culture medium addition tank of the organoid chip with a barrier structure, and the conditioned culture medium and the organoid maturation culture medium are added to the culture medium reservoir and the culture medium addition tank, respectively. The organoid is then placed on a precision seesaw shaker for long-term static or dynamic co-culture of the functionalized barrier structure and the organoid to obtain an organoid model with a barrier structure.

[0084] In the above technical solution,

[0085] When the endothelial cells are seeded on one side of the coated porous membrane, the number of cells seeded is 0.5×10 5 ~3×10 5 cells / microwell, and the liquid volume of the culture medium reservoir after inoculation is 0.3-1.5 mL;

[0086] When the cells for enhancing the barrier structure are seeded on the other side of the coated porous membrane, the number of cells seeded is 1×10 5 ~10×10 4 cells / microwell, and the liquid volume of the culture medium addition pool after inoculation is 200-800 μL.

[0087] The number of endothelial cells seeded was 0.5×10 5 ~3×10 5 cells / microwell, and the number of cells seeded to enhance the barrier structure was 1×10 4 ~1×10 5 The reasons for the number of cells / wells are:

[0088] If the number of cells is too small, it is not conducive to the rapid proliferation of the two types of cells to form a cell monolayer; if the number of cells is too large, it is not conducive to the normal proliferation and metabolism of the two types of cell monolayers.

[0089] When endothelial cells are seeded on the upper side of the coated porous membrane, the cells for enhancing the barrier structure are seeded on the lower side of the coated porous membrane; when endothelial cells are seeded on the lower side of the coated porous membrane, the cells for enhancing the barrier structure are seeded on the upper side of the coated porous membrane;

[0090] The endothelial cells or cells used to enhance the barrier structure are inoculated with a cell suspension or a mixture of a cell suspension and a matrix material. The mixture of a cell suspension and a matrix material is inoculated and solidified into a gel in a 37°C incubator for 3 to 8 minutes. The matrix material includes at least one of agarose, polyethylene glycol and sodium alginate. The reason for adding the matrix material is to simulate the structure, composition, physical properties and function of the basement membrane of cells in vivo and promote the culture and differentiation of barrier cells.

[0091] The cells used to enhance the barrier structure include pericytes, astrocytes, villous epithelial cells, choroidal epithelial cells, ependymal epithelial cells, microglia, oligodendrocytes, radial glial cells, and neuronal cells. When the cells used to enhance the barrier structure are pericytes, the culture medium for the cells used to enhance the barrier structure is pericyte culture medium;

[0092] When endothelial cells are seeded on the upper side of the coated porous membrane, the cells for enhancing the barrier structure are seeded on the lower side of the coated porous membrane; when endothelial cells are seeded on the lower side of the coated porous membrane, the cells for enhancing the barrier structure are seeded on the upper side of the coated porous membrane.

[0093] The type of organoid added to the culture medium addition pool includes one of brain organoids, placental organoids, intestinal organoids, kidney organoids, tumor organoids, and testicular organoids.

[0094] After the chip is coated, the background resistance value or porous membrane permeability of the chip is measured to determine the batch difference of the chip, so as to facilitate the subsequent functional identification.

[0095] The endothelial cell culture medium and the culture medium of cells for enhancing the barrier structure are prepared in a volume ratio of 1:9-4:6 to obtain a conditioned culture medium for co-culturing endothelial cells and cells for enhancing the barrier structure, which can mimic the cell composition and structure of the barrier in the body and promote the tightness of the barrier structure. The volume ratio range is conducive to improving the proliferation ability and activity of various barrier cells and simplifying the process of barrier model construction.

[0096] An organoid model with a barrier structure of the present application will be described in detail below with reference to the accompanying drawings.

[0097] In the following examples, endothelial cell culture medium was purchased from Sciencell, catalog number 1001; culture medium for cells used to enhance barrier structure was purchased from Sciencell, catalog number 1201; the formula of organoid (neural) maturation culture medium is: DMEM / F1224mL, Neurobasel medium 24mL, N2 supplement (100×) 250μL, B27 supplement (50×) 500μL, GlutaMAX (100×) 500μL, Human insulin 2.5μg / mL, Non-essential aminoacids (100×) 250μL, Beta-mercaptoethanol 25nM, Penicillin / streptomycin 1%.

[0098] Example 1 A brain organoid model with a blood-brain barrier and a construction method

[0099] 1. Brain organoid chip with blood-brain barrier

[0100] like Figure 1 As shown, an embodiment of the present invention provides a brain organoid chip with a blood-brain barrier, comprising:

[0101] A cell culture plate 1; an integrated microporous component 2, arranged in the cell culture plate 1; the integrated microporous component 2 comprises, from top to bottom, an upper element 21, a porous membrane 22 and a lower element 23; the upper element 22 comprises a first hollow part 211 and a second hollow part 212, wherein a pair of oppositely disposed side walls of the first hollow part 211 are both in contact with the inner wall of the cell culture plate 1, the middle of the first hollow part 211 is clamped with the second hollow part 212, and the second hollow part 212 connects the first The hollow part 211 is divided into a left culture medium reservoir 3 and a right culture medium reservoir 4, and the bottom of the second hollow part 212 is provided with the porous membrane 22 to form a culture medium liquid addition tank 5; the lower layer element 23 is hollow and the outer shape of the lower layer element 23 is adapted to the outer peripheral shape of the first hollow part 211, and the middle upper surface of the lower layer element 23 is used to support the porous membrane 22, and the bottom of the left culture medium reservoir 3 and the bottom of the right culture medium reservoir 4 form a culture medium perfusion channel 5 through the lower layer element 23.

[0102] In the embodiment of the present invention,

[0103] The hollow cross section of the second hollow part is in the shape of a ring. The height of the first hollow part is 8 mm; the height of the lower element is 1 mm. The straight-line distance between the two opposite side walls of the first hollow part is 21 mm; the straight-line distance between the two opposite side walls of the lower element is 21 mm.

[0104] The thickness of the porous membrane is 12 μm, the pore size is 0.4 μm, and the porosity is 2×10 6 Hole / cm 2 .

[0105] 2. Preparation method of brain organoid chip with blood-brain barrier

[0106] Step 1. For the type of human blood-brain barrier cells and the size of brain organoids, draw the corresponding upper and lower components of the microplate using CAD software according to their size;

[0107] Step 2: Use laser engraving technology or CNC machine tool engraving technology to process the PMMA plate to make upper and lower layer components;

[0108] Step 3, cutting the porous membrane according to the center shape of the upper element;

[0109] Step 4: Use PDMS to adhere the PMMA upper and lower layer components to the porous membrane to form a "sandwich" sandwich structure component, and further adhere the lower layer component side of the sandwich structure component to the cell culture plate to form a microporous plate;

[0110] Step 5, the microplate structure includes a substrate, a culture medium reservoir, a culture medium perfusion channel, and a culture medium addition reservoir;

[0111] Step 6. Use COMSOL software to model the designed chip and perform simulation verification of fluid flow, flow rate and material diffusion in the chip to confirm that there is stable fluid flow and physiologically relevant fluid shear force in the chip, and that the porous membrane separating the upper and lower chambers can achieve material diffusion.

[0112] 3. Construction of brain organoid model with blood-brain barrier

[0113] (1) The integrated microporous component is sterilized by ultraviolet light for 48 hours and leak tested for 4 hours. The substances used for leak testing include PBS, dyes, pigments, fluorescent substances, inks, etc.;

[0114] (2) Add gelatin solution to the perfusion channel of the microplate, so that the liquid stays between the microplate base and the porous membrane due to surface tension, and the microplate is coated in a 37°C incubator for 2-4 hours; after the chip is coated, the background resistance value or porous membrane permeability of the chip is measured to determine the batch difference of the chip, which is convenient for subsequent functional identification. The batch difference data of the background resistance value is as follows Fig.12 As shown;

[0115] (3) Remove the gelatin solution from the microplate and place the microplate in a biosafety cabinet or clean bench to air dry for 20 min.

[0116] (4) preparing conditioned medium by mixing endothelial cell culture medium and pericyte culture medium in a ratio of 2:8, and filtering the medium with a 0.22 μm filter; the endothelial cell culture medium was purchased from Sciencell with a catalog number of 1001, and the pericyte culture medium was purchased from Sciencell with a catalog number of 1201;

[0117] (5) Digest BMECs and adjust the cell concentration to 1.5×10 5 After 10 cells / microwell are inoculated to the lower side of the porous membrane of the microplate;

[0118] (6) After the endothelial cells adhered to the wall, BVPs (human brain vascular pericytes) were digested and the cell concentration was adjusted to 5×10 4 After 10 cells / microwell are inoculated to the upper side of the porous membrane of the microplate;

[0119] (7) After BMECs (human brain microvascular endothelial cells) and BVPs were co-cultured for 24 h, the human brain organoids were loaded into the microplate culture medium addition reservoir and neural differentiation or neural maturation medium was added;

[0120] (8) BMECs, BVPs, and brain organoids were co-cultured for a long time on a precision rocker shaker. The conditioned medium was replaced daily in the medium reservoir and medium perfusion channel, and the neural differentiation or neural maturation medium was replaced daily in the medium addition tank.

[0121] Example 2

[0122] In the embodiment of the present invention, the height of the first hollow member is 2 mm, and the height of the lower layer element is 0.5 mm. Other structures and steps are the same as those in the first embodiment.

[0123] Example 3

[0124] In the embodiment of the present invention, the height of the first hollow member is 15 mm; the height of the lower layer element is 3 mm. Other structures and steps are the same as those in the first embodiment.

[0125] Example 4

[0126] In the embodiment of the present invention, the height of the first hollow member is 2 mm; the height of the lower layer element is 0.5 mm. The thickness of the porous membrane is 5 μm, the pore size is 0.1 μm, and the porosity is 1×10 5 Hole / cm 2The other structures and steps are the same as those in Example 1.

[0127] Example 5

[0128] In the embodiment of the present invention, the height of the first hollow member is 2 mm; the height of the lower layer element is 0.5 mm. The thickness of the porous membrane is 20 μm, the pore size is 3 μm, and the porosity is 5×10 6 Hole / cm 2 The other structures and steps are the same as those in Example 1.

[0129] Example 6

[0130] In the embodiment of the present invention, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 4:6. Other structures and steps are the same as those in embodiment 1.

[0131] Example 7

[0132] In the embodiment of the present invention, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 1:9. Other structures and steps are the same as those in embodiment 1.

[0133] Example 8

[0134] In the embodiment of the present invention, the inoculation concentration of BMECs is 5×10 4 The other structures and steps are the same as those in Example 1.

[0135] Example 9

[0136] In the embodiment of the present invention, the inoculation concentration of BMECs is 3×10 5 The other structures and steps are the same as those in Example 1.

[0137] Example 10

[0138] In the embodiment of the present invention, the inoculation concentration of BVPs is 1×10 4 The other structures and steps are the same as those in Example 1.

[0139] Embodiment 11

[0140] In the embodiment of the present invention, the inoculation concentration of BMECs is 1×10 5 The other structures and steps are the same as those in Example 1.

[0141] Example 12

[0142] In the present embodiment, BVPs are replaced by astrocytes. Other structures and steps are the same as those in Example 1.

[0143] Embodiment 13

[0144] In the embodiment of the present invention, BVPs are replaced by choroid plexus epithelial cells. Other structures and steps are the same as those in embodiment 1.

[0145] Embodiment 14

[0146] In the embodiment of the present invention, BVPs are replaced by neurons. Other structures and steps are the same as those in embodiment 1.

[0147] Embodiment 15

[0148] In the embodiment of the present invention, the type of organoid added to the culture medium addition pool is placental organoid. Other structures and steps are the same as those in embodiment 1.

[0149] Example 16

[0150] In the embodiment of the present invention, the type of organoid added to the culture medium addition tank is testicular organoid. Other structures and steps are the same as those in embodiment 1.

[0151] Embodiment 17

[0152] In the embodiment of the present invention, the type of organoid added to the culture medium addition pool is tumor organoid. Other structures and steps are the same as those in embodiment 1.

[0153] Comparative Example 1

[0154] In Comparative Example 1, the height of the first hollow member is 0.5 mm, and the height of the lower layer element is 0.1 mm. Other structures and steps are the same as those in Example 1.

[0155] Comparative Example 2

[0156] In Comparative Example 2, the height of the first hollow member is 20 mm, and the height of the lower layer element is 5 mm. Other structures and steps are the same as those in Example 1.

[0157] Comparative Example 3

[0158] In Comparative Example 3, the thickness of the porous membrane is 2 μm. Other structures and steps are the same as those in Example 1.

[0159] Comparative Example 4

[0160] In Comparative Example 4, the thickness of the porous membrane is 30 μm. Other structures and steps are the same as those in Example 1.

[0161] Comparative Example 5

[0162] In Comparative Example 5, the pore size of the porous membrane is 8 μm. Other structures and steps are the same as those in Example 1.

[0163] Comparative Example 6

[0164] In Comparative Example 6, the pore size of the porous membrane is 12 μm. Other structures and steps are the same as those in Example 1.

[0165] Comparative Example 7

[0166] In Comparative Example 7, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 5:5. Other structures and steps are the same as those in Example 1.

[0167] Comparative Example 8

[0168] In Comparative Example 8, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 9:1. Other structures and steps are the same as those in Example 1.

[0169] Comparative Example 9

[0170] In Comparative Example 9, the inoculation concentration of BMECs was 1×10 4 The other structures and steps are the same as those in Example 1.

[0171] Comparative Example 10

[0172] In Comparative Example 10, the inoculation concentration of BMECs was 5×10 5 The other structures and steps are the same as those in Example 1.

[0173] Comparative Example 11

[0174] In Comparative Example 11, the inoculation concentration of BVPs was 5×10 3 The other structures and steps are the same as those in Example 1.

[0175] Comparative Example 12

[0176] In Comparative Example 12, the inoculation concentration of the BVPCs was 3×10 5 The other structures and steps are the same as those in Example 1.

[0177] Experimental Example 1

[0178] 1. The organoid models with barrier structures of each embodiment and each comparative example were cultured as follows:

[0179] 1. Chip production and sterilization: Use CAD and laser engraving machine to draw and manufacture the upper and lower components of the chip, cut the porous membrane into the shape of the second hollow part of the upper component, use PDMS to adhere the upper component, porous membrane, and lower component in sequence to form a "sandwich"-like sandwich structure microplate assembly, and further use PDMS to adhere the assembly to the cell culture plate. Use COMSOL software to model the designed chip, and simulate and verify the fluid flow, flow rate, and material diffusion in the chip to determine that there is stable fluid flow and physiologically relevant fluid shear force in the chip, and the porous membrane separating the upper and lower chambers can achieve material diffusion. Sterilize the chip by ultraviolet for 48 hours, and use buffer to perform a leak test on the chip for 4 hours.

[0180] 2. Construction of functional barrier structure: Use 0.1% Gelatin to coat the bottom of the porous membrane. 5 The BMECs suspension of 10 cells / microwell was added into the gap between the porous membrane and the base of the cell culture plate. The suspension was retained by the surface tension of the liquid, and the chip was inverted in the incubator for 4-6 hours to promote cell adhesion. 4 The BVPs suspension for enhancing the barrier structure with 1 cell / micropore is added to the culture medium addition pool, and the chip is placed upright in the incubator for 4-6 hours to promote cell attachment to the upper side of the porous membrane. The chip is placed on a precision rocker shaker to perform perfusion culture of the barrier cells on the porous membrane by gravity.

[0181] 3. Construction of an organoid model with a barrier structure: After 24 hours of co-culture of BMECs and BVPs, remove the conditioned medium in the culture medium tank. Use organoid maturation medium to load the brain organoids into the culture medium tank. Place the chip on a precision rocker and perform long-term dynamic co-culture in an incubator. Replace the conditioned medium in the chip culture medium reservoir and the organoid maturation medium in the culture medium tank every day.

[0182] 2. The barrier properties of the blood-brain barrier structure in the brain organoid models with a blood-brain barrier of the above Examples 1-17 and Comparative Examples 1-12 and the effect of maintaining the biological morphology of the brain organoids were evaluated. The results are shown in Table 1;

[0183] Table 1

[0184]

[0185]

[0186]

[0187]

[0188] From Table 1, we can see that

[0189] In Comparative Example 1, the height of the first hollow part is 0.5 mm, which is smaller than the range of 2 to 15 mm in the embodiment of the present invention; the height of the lower layer element is 0.1 mm, which is smaller than the range of 0.5 to 3 mm in the embodiment of the present invention. The obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0190] In Comparative Example 2, the height of the first hollow member is 20 mm, which is larger than the range of 2 to 15 mm in the embodiment of the present invention; the height of the lower element is 5 mm, which is larger than the range of 2 to 15 mm in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0191] In Comparative Example 3, the thickness of the porous membrane is 2 μm, which is smaller than the range of 5 to 20 μm in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0192] In Comparative Example 4, the thickness of the porous membrane is 30 μm, which is greater than the range of 5 to 20 μm in the embodiment of the present invention. The obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0193] In Comparative Example 5, the pore size of the porous membrane is 8 μm, which is larger than the range of 0.1 to 3 μm in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties;

[0194] In Comparative Example 6, the pore size of the porous membrane is 12 μm, which is larger than the range of 0.1 to 3 μm in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties;

[0195] In Comparative Example 7, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 5:5, which is not within the range of the volume ratio of 1:9-4:6 in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0196] In Comparative Example 8, the conditioned medium is a mixed medium of endothelial cell medium and pericyte medium in a ratio of 9:1, which is not within the range of the volume ratio of 1:9-4:6 in the embodiment of the present invention, and the obtained barrier structure does not have barrier properties, and the biological morphology of the organoid cannot be maintained;

[0197] In Comparative Example 9, the inoculation concentration of BMECs was 1×10 4 cells / microwell, which is less than 0.5×10 5 ~3×10 5 The barrier structure obtained does not have barrier properties;

[0198] In Comparative Example 10, the inoculation concentration of BMECs was 5×10 5 cells / microwell, which is greater than 0.5×10 5 ~3×10 5 The biological morphology of organoids cannot be maintained within the range of 1 cell / microwell.

[0199] In Comparative Example 11, the inoculation concentration of BVPs was 5×10 3 cells / microwell, which is less than 1×10 5 ~10×10 4 The barrier structure obtained does not have barrier properties;

[0200] In Comparative Example 12, the inoculation concentration of the BVPCs was 3×10 5 cells / microwell, which is greater than 1×10 5 ~10×10 4 The biological morphology of organoids cannot be maintained if the cell / well limit is exceeded.

[0201] The barrier structures obtained in Examples 1 to 17 of the present invention have barrier properties, and the biological morphology of the organoids can be maintained for about 7 days.

[0202] Experimental Example 2: Performance measurement of brain organoid model with blood-brain barrier

[0203] 1. The organoid chip with a barrier structure designed and manufactured using the method of Example 1 was simulated and verified. Figure 3 is the material diffusion simulation result of the chip in the present invention, Figure 3 It can be seen that the chip can quickly achieve material diffusion through the upper and lower chambers separated by the porous membrane, meeting the basic conditions for material exchange in the subsequent model construction.

[0204] 2. The conditioned medium screened by the method of Example 1 was used to identify cell activity, cell functional genes and cell morphology. Figure 5 The effect of the conditioned medium of the present invention on the cell proliferation activity, functional gene expression and cell morphology of BMECs and BVPs is shown in FIG. Figure 5 It can be seen that the conditioned medium can significantly promote the activity of the two cell types without significantly affecting the expression of the functional genes of the two cell types and the cell morphology and structure, indicating that the conditioned medium is helpful in constructing a functional BBB.

[0205] 3. Imaging of brain organoids with a blood-brain barrier cultured using the method of Example 1. Figure 6 is the bright field imaging result of blood-brain barrier cells and organoids in the present invention, Figure 6It can be seen that BMECs and BVPs can be successfully attached to the porous membrane and grow normally. Human brain organoids co-cultured with the blood-brain barrier structure for a long time can still maintain the basic morphology of brain organoids, and the typical neural rosette structure can be maintained, indicating that the blood-brain barrier structure and human organoids can be co-cultured in a long-term steady state.

[0206] 4. Perform blood-brain barrier immunofluorescence imaging in brain organoids with a blood-brain barrier cultured using the method of Example 1. Figure 7 The fluorescence imaging results of BMECs and BVPs cells in the present invention are shown in FIG. Figure 7 It can be seen that BMECs and BVPs can successfully attach to the porous membrane and grow normally, forming a monolayer structure on both sides of the porous membrane and expressing corresponding functional markers, indicating that long-term co-culture of brain organoids and BBB will not affect the structure and function of the BBB.

[0207] 5. Perform BBB functional analysis on brain organoids with blood-brain barrier cultured using the method of Example 1. Figure 8 is the functional analysis result of the blood-brain barrier in the brain organoid with blood-brain barrier in the present invention, Figure 8 It can be seen that brain organoids with a blood-brain barrier have the ability to significantly enhance and maintain barrier function for a long time, and have better and more consistent blocking capabilities in terms of molecular permeability.

[0208] 6. RT-qPCR analysis of BBB functional genes was performed on brain organoids with blood-brain barrier cultured using the method of Example 1 (analysis reagent: SYBR Green Real-time PCR Master Mix; primer sequences are shown in Table 2).

[0209] Table 2

[0210]

[0211] Fig. 9 is the RT-qPCR result of the functional gene of the blood-brain barrier in the cerebral organoid with the blood-brain barrier in the present invention, Fig. 9 It can be seen that brain organoids with blood-brain barrier have no difference in the expression of endothelial cell markers and blood-brain barrier tight junctions compared with conventional brain microvascular endothelial cells, and significantly improve the functional gene expression level of pericytes.

[0212] 7. Immunofluorescence analysis was performed on brain organoids with a blood-brain barrier cultured using the method of Example 1. Fig.10 is the immunofluorescence analysis result of the cerebral organoids in the cerebral organoids with blood-brain barrier in the present invention, Fig.10It can be seen that human brain organoids co-cultured with blood-brain barrier structures for a long time can still normally recapitulate the conventional neural cell types of brain organoids and have normal expression of regional markers of brain structures.

[0213] 8. Perform RT-qPCR analysis on the brain organoids cultured using the method of Example 1 (analysis reagent: SYBRGreen Real-time PCR Master Mix; primer sequences are shown in Table 3). Fig.11 is the immunofluorescence analysis result of the cerebral organoids in the cerebral organoids with blood-brain barrier in the present invention, Fig.11 It can be seen that human brain organoids co-cultured with blood-brain barrier structures for a long time can still normally express representative functional genes of various neural cells and brain region structures at the transcriptional level.

[0214] Table 3

[0215]

[0216]

[0217] 9. The method of Example 1 was used to determine the background resistance of the organoid chip with a barrier structure after coating. Fig.12 is the measurement result of the background resistance value, Fig.12 It can be seen that there is no significant difference in the background resistance values ​​between multiple batches of chips, indicating that the chip processing is highly consistent and will not affect the results of functional characterization during the model construction process.

[0218] Finally, it should be noted that the terms "comprises," "includes," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements that are inherent to such process, method, article, or apparatus.

[0219] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.

[0220] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A method for constructing an organoid model with a barrier structure, characterized in that: The method comprises: An organoid chip with a barrier structure is obtained, comprising: a cell culture plate and an integrated microporous component arranged in the cell culture plate, wherein the integrated microporous component comprises, from top to bottom, an upper layer element, a porous membrane and a lower layer element; the upper layer element comprises a first hollow part and a second hollow part, wherein a pair of oppositely arranged side walls of the first hollow part are both in contact with the inner wall of the cell culture plate, the middle of the first hollow part is clamped with the second hollow part, the second hollow part divides the first hollow part into a left culture medium reservoir and a right culture medium reservoir, and the bottom of the second hollow part is provided with a The porous membrane forms a culture medium liquid addition pool; the lower layer element is hollow and the shape of the lower layer element is adapted to the outer peripheral shape of the first hollow part; the middle upper surface of the lower layer element is used to support the porous membrane; the bottom of the left culture medium reservoir and the bottom of the right culture medium reservoir are connected through the bottom of the lower layer element to form a culture medium perfusion channel; the height of the first hollow part is 2 to 15 mm; the height of the lower layer element is 0.5 to 3 mm; the thickness of the porous membrane is 5 to 20 μm, the pore size is 0.1 to 3 μm, and the porosity is 1×10 5 ~5×10 6 Hole / cm 2 ; After sterilizing the organoid chip with a barrier structure, the porous membrane is coated; the endothelial cell culture medium and the culture medium of the cells for enhancing the barrier structure are prepared in a volume ratio of 1:9-4:6 to obtain a conditioned medium; the endothelial cells are inoculated on one side of the coated porous membrane, the cells for enhancing the barrier structure are inoculated on the other side of the coated porous membrane, and the endothelial cells and the cells for enhancing the barrier structure are co-cultured using the conditioned medium; After 12 to 72 hours of co-culture, the organoid is loaded into the culture medium addition tank of the chip, and the conditioned medium and the culture medium for organoid maturation are added to the culture medium reservoir and the culture medium addition tank, respectively, and then placed on a precision seesaw shaker for long-term dynamic co-culture of the functionalized barrier structure and the organoid, to obtain an organoid model with a barrier structure; Among them, the cells used to enhance the barrier structure include one of pericytes, astrocytes, choroidal epithelial cells, and neuronal cells; the type of organoids added to the culture medium addition pool includes one of brain organoids, placental organoids, tumor organoids, and testicular organoids.

2. The method for constructing an organoid model with a barrier structure according to claim 1, characterized in that: When the endothelial cells are seeded on one side of the coated porous membrane, the number of cells seeded is 0.5×10 5 ~3×10 5 cells / microwell, and the liquid volume of the culture medium reservoir after inoculation is 0.3-1.5 mL; When the cells for enhancing the barrier structure are seeded on the other side of the coated porous membrane, the number of cells seeded is 1×10 4 ~1×10 5 cells / microwell, and the liquid volume of the culture medium addition pool after inoculation is 200-800 μL.

3. The method for constructing an organoid model with a barrier structure according to claim 2, characterized in that: The endothelial cells or cells used to enhance the barrier structure are inoculated using a cell suspension or a mixture of a cell suspension and a matrix material. The mixture of the cell suspension and the matrix material is inoculated and solidified into a gel in a 37° C. incubator for 3 to 8 minutes. The matrix material includes at least one of agarose, polyethylene glycol and sodium alginate.

4. The method for constructing an organoid model with a barrier structure according to claim 1, characterized in that: After the chip is coated, the background resistance value or porous membrane permeability of the chip is measured.

5. An organoid model with a barrier structure prepared by the method according to any one of claims 1 to 4.

6. The organoid model with barrier structure according to claim 5, characterized in that: The barrier structure includes at least one of a blood-brain barrier, a blood-cerebrospinal fluid barrier, a cerebrospinal fluid-brain barrier, a blood-tumor barrier, a placental barrier, and a blood-testis barrier; the organoid includes one of a brain organoid, a placental organoid, a tumor organoid, and a testicular organoid.

7. An organoid chip with a barrier structure according to claim 1, characterized in that: The organoid chip with a barrier structure comprises: Cell culture plates; The integrated microporous component is arranged in the cell culture plate; the integrated microporous component comprises, from top to bottom, an upper layer element, a porous membrane and a lower layer element; the upper layer element comprises a first hollow part and a second hollow part, a pair of oppositely arranged side walls of the first hollow part are both in contact with the inner wall of the cell culture plate, the middle of the first hollow part is clamped with the second hollow part, the second hollow part divides the first hollow part into a left culture medium reservoir and a right culture medium reservoir, the bottom of the second hollow part is provided with the porous membrane to form a culture medium reservoir, and the porous membrane is provided at the bottom of the second hollow part. The lower layer element is hollow and its shape matches the outer shape of the first hollow part. The upper surface of the middle part of the lower layer element is used to support the porous membrane. The bottom of the left culture medium reservoir and the bottom of the right culture medium reservoir form a culture medium perfusion channel through the lower layer element. The height of the first hollow part is 2 to 15 mm. The height of the lower layer element is 0.5 to 3 mm. The thickness of the porous membrane is 5 to 20 μm, the pore size is 0.1 to 3 μm, and the porosity is 1×10 5 ~5×10 6 Hole / cm 2 .

Citation Information

Patent Citations

  • Gestational maternal-fetal interface ZIKA virus infection model construction method based on organ-on-chip

    CN117106699A

  • Cell culture system for perfusable networks of self-assembled cells

    US20230174909A1